| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Doyle James Edward serves as a Director at EXAS. Across recent SEC filings that breaks down to 1 buy and 14 sells.
Historically, Doyle James Edward's trades have earned a strong insider score of 75/100 across 7 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +44.4%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 9, 2025 | EXAS Exact Sciences Corp | Director | Sell | 2,000 | $60.00 | $120,000.00 | -3.3% | +70.9% | - | |
| Aug 13, 2025 | EXAS Exact Sciences Corp | Director | Sell | 1,485 | $42.02 | $62,399.70 | -2.4% | +50.3% | - | |
| Mar 1, 2024 | EXAS Exact Sciences Corp | Director | Sell | 2,000 | $57.50 | $115,000.00 | -3.8% | -23.9% | -20.2% | |
| Jul 27, 2023 | EXAS Exact Sciences Corp | Director | Sell | 2,000 | $97.42 | $194,840.00 | -3.7% | -36.4% | -53.4% | |
| Jun 9, 2023 | EXAS Exact Sciences Corp | Director | Sell | 1,402 | $90.51 | $126,895.02 | -2.5% | -10.2% | -51.1% | |
| May 26, 2023 | EXAS Exact Sciences Corp | Director | Sell | 2,000 | $80.62 | $161,240.00 | -3.7% | -2.9% | -39.2% | |
| Jul 30, 2021 | EXAS Exact Sciences Corp | Director | Sell | 2,640 | $111.17 | $293,488.80 | -8.1% | -10.3% | -58.2% | |
| Feb 26, 2021 | EXAS Exact Sciences Corp | Director | Sell | 2,000 | $130.11 | $260,220.00 | -6.2% | - | - | |
| Jul 31, 2020 | EXAS Exact Sciences Corp | Director | Sell | 2,539 | $94.00 | $238,666.00 | -7.3% | - | - | |
| Feb 28, 2020 | EXAS Exact Sciences Corp | Director | Sell | 2,000 | $77.54 | $155,080.00 | -5.8% | - | - |